Walder Wyss advised Vandria SA in this transaction.Vandria SA, a company developing mitochondrial therapeutics, including first-in-class small molecule mitophagy inducers, today emerged from stealth with the…
Vandria SA’s $20.6 Million Round Financing From ND Capital
